James E. Flynn

Insider Reports History

Location
New York, NY
Signature
/s/ Jonathan Isler, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James E. Flynn:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nuvalent, Inc. Director, Director by Deputization, 10%+ Owner Class A Common Stock 8,299,225 $792,119,530 $95.44 24 Nov 2025 Through Deerfield Healthcare Innovations Fund, L.P.
Nuvalent, Inc. Director, Director by Deputization, 10%+ Owner Class A Common Stock 8,299,225 $792,119,530 $95.44 24 Nov 2025 Through Deerfield Private Design Fund IV, L.P.
AdaptHealth Corp. *Possible Member of 10% Group, 10%+ Owner Class A Common Stock 11,528,863 $123,358,834 $10.7 12 Mar 2024 Through Deerfield Partners, L.P.
ARS Pharmaceuticals, Inc. 10%+ Owner Class A Common Stock 4,887,254 $90,218,708 $18.46 27 Jun 2025 Through Deerfield Private Design Fund III, L.P.
ARS Pharmaceuticals, Inc. 10%+ Owner Class A Common Stock 4,887,254 $90,218,708 $18.46 27 Jun 2025 Through Deerfield Private Design Fund IV, L.P.
Nuvalent, Inc. Director, Director by Deputization, 10%+ Owner Class A Common Stock 650,000 $55,029,000 $84.66 24 Nov 2025 Through Deerfield Partners, L.P.
CareMax, Inc. Director, Director by Deputization, 10%+ Owner Class A Common Stock 15,811,090 $54,706,371 $3.46 17 Nov 2023 Through Deerfield Partners, L.P.
Mirum Pharmaceuticals, Inc. * Possible Member of 10% Group, 10%+ Owner Common Stock 1,704,244 $47,778,651 $28.04 06 Jun 2022 Through Deerfield Private Design Fund IV, L.P.
Mirum Pharmaceuticals, Inc. * Possible Member of 10% Group, 10%+ Owner Common Stock 1,540,190 $43,179,381 $28.04 06 Jun 2022 Through Deerfield Healthcare Innovations Fund, L.P.
Larimar Therapeutics, Inc. Director, * Director by Deputization, 10%+ Owner Common Stock 9,538,945 $30,524,624 $3.2 31 Jul 2025 Through Deerfield Private Design Fund IV, L.P.
Larimar Therapeutics, Inc. Director, * Director by Deputization, 10%+ Owner Common Stock 9,538,918 $30,524,537 $3.2 31 Jul 2025 Through Deerfield Private Design Fund III, L.P.
Larimar Therapeutics, Inc. Director, * Director by Deputization, 10%+ Owner Common Stock 7,321,129 $23,427,612 $3.2 31 Jul 2025 Through Deerfield Healthcare Innovations Fund, L.P.
AdaptHealth Corp. *Possible Member of 10% Group, 10%+ Owner Class A Common Stock 1,709,077 $18,287,124 $10.7 08 Mar 2024 Through Deerfield Private Design Fund IV, L.P.
Larimar Therapeutics, Inc. Director, * Director by Deputization, 10%+ Owner Common Stock 4,207,982 $14,643,777 $3.48 31 Jul 2025 Through Deerfield Partners, L.P.
Bicara Therapeutics Inc. Possible Members of 10% Group, 10%+ Owner Common Stock 897,587 $11,887,104 $13.24 17 Sep 2024 Through Deerfield Partners, L.P.
Bicara Therapeutics Inc. Possible Members of 10% Group, 10%+ Owner Common Stock 897,587 $11,887,104 $13.24 17 Sep 2024 Through Deerfield Private Design Fund V, L.P.
Singular Genomics Systems, Inc. *Possible Member of 10% Group, 10%+ Owner Common Stock 7,484,871 $3,169,094 $0.4234 01 Jun 2021 Through Deerfield Private Design Fund IV, L.P.
Acutus Medical, Inc. Director, Director by deputization Common Stock 1,622,143 $2,530,543 $1.56 27 Jan 2025 Through Deerfield Private Design Fund III, L.P.
Fractyl Health, Inc. Possible Members of 10% Group, 10%+ Owner Common Stock 834,254 $2,419,003 $2.9 06 Feb 2024 Through Deerfield Private Design Fund III, L.P.
PepGen Inc. Possible Member of 10% Group, 10%+ Owner Common Stock 476,813 $1,985,926 $4.16 10 May 2022 Through Deerfield Partners, L.P.
PepGen Inc. Possible Member of 10% Group, 10%+ Owner Common Stock 476,813 $1,985,926 $4.16 10 May 2022 Through Deerfield Private Design Fund V, L.P.
Acutus Medical, Inc. Director, Director by deputization Common Stock 1,026,243 $1,600,939 $1.56 27 Jan 2025 Through Deerfield Partners, L.P.
BiomX Inc. Director, *Director by Deputization Common Stock 1,247,054 $1,160,508 $0.9306 27 Feb 2025 Through Deerfield Healthcare Innovations Fund II, L.P.
BiomX Inc. Director, *Director by Deputization Common Stock 1,247,054 $1,160,508 $0.9306 27 Feb 2025 Through Deerfield Private Design Fund V, L.P.
Xilio Therapeutics, Inc. Possible Member of 10% Group, 10%+ Owner Common Stock 1,143,972 $949,497 $0.83 26 Oct 2021 Through Deerfield Partners, L.P.
Xilio Therapeutics, Inc. Possible Member of 10% Group, 10%+ Owner Common Stock 1,143,972 $949,497 $0.83 26 Oct 2021 Through Deerfield Private Design Fund V, L.P.
Singular Genomics Systems, Inc. *Possible Member of 10% Group, 10%+ Owner Common Stock 1,627,148 $688,934 $0.4234 01 Jun 2021 Through Deerfield Partners, L.P.
Oncology Institute, Inc. Possible Members of 10% Group, 10%+ Owner Class A Common Stock 1,605,477 $218,345 $0.136 12 Nov 2021 Through Deerfield Partners, L.P.
Oncology Institute, Inc. Possible Members of 10% Group, 10%+ Owner Class A Common Stock 1,605,477 $218,345 $0.136 12 Nov 2021 Through Deerfield Private Design Fund IV, L.P.
AdaptHealth Corp. *Possible Member of 10% Group, 10%+ Owner Class A Common Stock 20,000 $214,000 $10.7 08 Mar 2024 Through Deerfield Management Company, L.P.
CareMax, Inc. Director, Director by Deputization, 10%+ Owner Class A Common Stock 12,123 $41,946 $3.46 17 Nov 2023 Through Deerfield Management Company, L.P.
Singular Genomics Systems, Inc. *Possible Member of 10% Group, 10%+ Owner Stock Option (Right to Buy) 30,000 $33,000 $1.1 01 Jun 2021 Through Deerfield Management Company, L.P.
Acutus Medical, Inc. Director, Director by deputization Common Stock 20,822 $32,482 $1.56 27 Jan 2025 Through Deerfield Management Company, L.P.
Oncology Institute, Inc. Possible Members of 10% Group, 10%+ Owner Class A Common Stock 85,113 $11,575 $0.136 12 Nov 2021 Through Deerfield Management Company, L.P.
Oncology Institute, Inc. Possible Members of 10% Group, 10%+ Owner Class A Common Stock 40 $5 $0.136 12 Nov 2021 Through DFP Sponsor, LLC
Oncology Institute, Inc. Possible Members of 10% Group, 10%+ Owner Private Placement Warrants 3,177,543 12 Nov 2021 Through DFP Sponsor, LLC
Frazier Lifesciences Acquisition Corp Possible Member of 10% Group, 10%+ Owner Class A Ordinary Shares 2,480,199 08 Nov 2022 Through Deerfield Partners, L.P.
Acutus Medical, Inc. Director, Director by deputization Series A Common Stock Equivalent Convertible Preferred Stock 1,816,446 27 Jan 2025 Through Deerfield Private Design Fund III, L.P.
BiomX Inc. Director, *Director by Deputization Warrants 1,611,864 21 Apr 2025 Through Deerfield Healthcare Innovations Fund II, L.P.
BiomX Inc. Director, *Director by Deputization Warrants 1,611,864 21 Apr 2025 Through Deerfield Private Design Fund V, L.P.
Oncorus, Inc. Possible Member of 10% Group, 10%+ Owner Common Stock 1,156,309 30 Dec 2022 Through Deerfield Healthcare Innovations Fund, L.P.
Oncorus, Inc. Possible Member of 10% Group, 10%+ Owner Common Stock 1,156,308 30 Dec 2022 Through Deerfield Private Design Fund III, L.P.
Acutus Medical, Inc. Director, Director by deputization Series A Common Stock Equivalent Convertible Preferred Stock 948,395 27 Jan 2025 Through Deerfield Partners, L.P.
Oncology Institute, Inc. Possible Members of 10% Group, 10%+ Owner Public Warrants 625,000 12 Nov 2021 Through Deerfield Partners, L.P.
Oncology Institute, Inc. Possible Members of 10% Group, 10%+ Owner Public Warrants 625,000 12 Nov 2021 Through Deerfield Private Design Fund IV, L.P.
Oncorus, Inc. Possible Member of 10% Group, 10%+ Owner Common Stock 284,697 30 Dec 2022 Through Deerfield Partners, L.P.
Oncology Institute, Inc. Possible Members of 10% Group, 10%+ Owner Series A Common Stock Equivalent Convertible Preferred Stock 58,945 12 Nov 2021 Through Deerfield Partners, L.P.
Oncology Institute, Inc. Possible Members of 10% Group, 10%+ Owner Series A Common Stock Equivalent Convertible Preferred Stock 58,945 12 Nov 2021 Through Deerfield Private Design Fund IV, L.P.
BiomX Inc. Director, *Director by Deputization Series X Non-Voting Convertible Preferred Stock 47,957 15 Jul 2024 Through Deerfield Healthcare Innovations Fund II, L.P.
BiomX Inc. Director, *Director by Deputization Series X Non-Voting Convertible Preferred Stock 47,957 15 Jul 2024 Through Deerfield Private Design Fund V, L.P.
Oncology Institute, Inc. Possible Members of 10% Group, 10%+ Owner Series A Common Stock Equivalent Convertible Preferred Stock 45,620 12 Nov 2021 Through DFP Sponsor, LLC
Larimar Therapeutics, Inc. Director, * Director by Deputization, 10%+ Owner Stock Option (Right to Buy) 19,000 13 May 2025 Through Deerfield Management Company, L.P.
BiomX Inc. Director, *Director by Deputization Stock Option (Right to Buy) 17,600 14 Apr 2025 Through Deerfield Management Company, L.P.
Nuvalent, Inc. Director, Director by Deputization, 10%+ Owner Stock Option (Right to Buy) 4,147 18 Jun 2025 Through Deerfield Management Company, L.P.
Acutus Medical, Inc. Director, Director by deputization Warrant to Purchase Common Stock 0 27 Jan 2025 Through Deerfield Partners, L.P.
Acutus Medical, Inc. Director, Director by deputization Warrant to Purchase Common Stock 0 27 Jan 2025 Through Deerfield Private Design Fund III, L.P.
Bicara Therapeutics Inc. Possible Members of 10% Group, 10%+ Owner Series C Preferred Stock 0 17 Sep 2024 Through Deerfield Partners, L.P.
Bicara Therapeutics Inc. Possible Members of 10% Group, 10%+ Owner Series C Preferred Stock 0 17 Sep 2024 Through Deerfield Private Design Fund V, L.P.
CareMax, Inc. Director, Director by Deputization, 10%+ Owner Restricted Stock Units 0 $3.46 17 Nov 2023 Through Deerfield Management Company, L.P.
Fractyl Health, Inc. Possible Members of 10% Group, 10%+ Owner Series C-2 Preferred Stock 0 06 Feb 2024 Through Deerfield Private Design Fund III, L.P.
Fractyl Health, Inc. Possible Members of 10% Group, 10%+ Owner Series D Preferred Stock 0 06 Feb 2024 Through Deerfield Private Design Fund III, L.P.
Oncology Institute, Inc. Possible Members of 10% Group, 10%+ Owner Class B Common Stock 0 12 Nov 2021 Through Deerfield Management Company, L.P.
Oncology Institute, Inc. Possible Members of 10% Group, 10%+ Owner Class B Common Stock 0 12 Nov 2021 Through DFP Sponsor, LLC
PepGen Inc. Possible Member of 10% Group, 10%+ Owner Series B Preferred Stock 0 10 May 2022 Through Deerfield Partners, L.P.
PepGen Inc. Possible Member of 10% Group, 10%+ Owner Series B Preferred Stock 0 10 May 2022 Through Deerfield Private Design Fund V, L.P.
Singular Genomics Systems, Inc. *Possible Member of 10% Group, 10%+ Owner 6% Convertible Note due 2023 0 01 Jun 2021 Through Deerfield Partners, L.P.
Singular Genomics Systems, Inc. *Possible Member of 10% Group, 10%+ Owner 6% Convertible Note due 2023 0 01 Jun 2021 Through Deerfield Private Design Fund IV, L.P.
Singular Genomics Systems, Inc. *Possible Member of 10% Group, 10%+ Owner Series B Preferred Stock 0 01 Jun 2021 Through Deerfield Private Design Fund IV, L.P.
Xilio Therapeutics, Inc. Possible Member of 10% Group, 10%+ Owner Series C Preferred Stock 0 26 Oct 2021 Through Deerfield Partners, L.P.
Xilio Therapeutics, Inc. Possible Member of 10% Group, 10%+ Owner Series C Preferred Stock 0 26 Oct 2021 Through Deerfield Private Design Fund V, L.P.

Insider Reports Filed by James E. Flynn

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NUVL Nuvalent, Inc. 24 Nov 2025 2 -$70,874,975 4 Director, Director by Deputization, 10%+ Owner 24 Nov 2025, 20:00
LRMR Larimar Therapeutics, Inc. 31 Jul 2025 3 $30,000,000 4 Director, * Director by Deputization, 10%+ Owner 04 Aug 2025, 18:28
SPRY ARS Pharmaceuticals, Inc. 27 Jun 2025 2 -$13,663,150 4 10%+ Owner 01 Jul 2025, 16:42
NUVL Nuvalent, Inc. 18 Jun 2025 4 $0 4 Director, Director by Deputization, 10%+ Owner 20 Jun 2025, 21:08
LRMR Larimar Therapeutics, Inc. 13 May 2025 1 $0 4 Director, * Director by Deputization, 10%+ Owner 15 May 2025, 19:44
PHGE BiomX Inc. 21 Apr 2025 2 $0 4 Director, *Director by Deputization 23 Apr 2025, 17:49
PHGE BiomX Inc. 14 Apr 2025 1 $0 4 Director, *Director by Deputization 18 Apr 2025, 17:28
PHGE BiomX Inc. 27 Feb 2025 6 $657,467 4 Director, *Director by Deputization 03 Mar 2025, 19:02
AFIB Acutus Medical, Inc. 27 Jan 2025 5 $0 4 Director, Director by deputization 28 Jan 2025, 21:00
SPRY ARS Pharmaceuticals, Inc. 11 Nov 2024 8 -$10,143,705 4 10%+ Owner 13 Nov 2024, 20:16
NUVL Nuvalent, Inc. 22 Oct 2024 2 -$195,500,000 4 Director, * Director by deputization, 10%+ Owner 24 Oct 2024, 16:08
BCAX Bicara Therapeutics Inc. 17 Sep 2024 6 $1,260,000 4 Possible Members of 10% Group, 10%+ Owner 17 Sep 2024, 18:16
BCAX Bicara Therapeutics Inc. 12 Sep 2024 0 $0 3 *Possible Member of 10% Group, 10%+ Owner 12 Sep 2024, 21:07
PHGE BiomX Inc. 15 Jul 2024 4 $0 4 Director, *Director by Deputization 17 Jul 2024, 18:09
PHGE BiomX Inc. 11 Jul 2024 1 $0 4 Director, *Director by Deputization 15 Jul 2024, 19:19
PHGE BiomX Inc. 09 Jul 2024 4 $0 4 Director, *Director by Deputization, 10%+ Owner 11 Jul 2024, 18:47
NUVL Nuvalent, Inc. 12 Jun 2024 4 $0 4 Director, Director by Deputization, 10%+ Owner 14 Jun 2024, 17:05
LRMR Larimar Therapeutics, Inc. 29 May 2024 1 $0 4 Director, * Director by Deputization, 10%+ Owner 03 Jun 2024, 18:31
PHGE BiomX Inc. 15 Mar 2024 6 $0 4 Director, *Director by Deputization, 10%+ Owner 19 Mar 2024, 21:39
PHGE BiomX Inc. 15 Mar 2024 0 $0 3 Director, *Director by Deputization 19 Mar 2024, 21:28
AHCO AdaptHealth Corp. 08 Mar 2024 5 -$3,815,703 4 *Possible Member of 10% Group, 10%+ Owner 12 Mar 2024, 19:01
AHCO AdaptHealth Corp. 27 Feb 2024 0 $0 3 *Possible Member of 10% Group, 10%+ Owner 08 Mar 2024, 17:43
LRMR Larimar Therapeutics, Inc. 16 Feb 2024 3 $37,499,992 4 Director, * Director by Deputization, 10%+ Owner 16 Feb 2024, 14:37
GUTS Fractyl Health, Inc. 06 Feb 2024 4 $0 4 Possible Members of 10% Group, 10%+ Owner 08 Feb 2024, 14:07
GUTS Fractyl Health, Inc. 01 Feb 2024 0 $0 3 Possible Member of 10% Group, 10%+ Owner 01 Feb 2024, 18:55
CMAX CareMax, Inc. 17 Nov 2023 2 $0 4 Director, Director by Deputization, 10%+ Owner 21 Nov 2023, 18:09
NUVL Nuvalent, Inc. 15 Jun 2023 2 $0 4 Director, Director by deputization, 10%+ Owner 16 Jun 2023, 18:46
CMAX CareMax, Inc. 08 Jun 2023 1 $0 4 Director, Director by Deputization, 10%+ Owner 12 Jun 2023, 20:18
LRMR Larimar Therapeutics, Inc. 09 May 2023 1 $0 4 Director, * Director by Deputization, 10%+ Owner 11 May 2023, 18:31
ONCR Oncorus, Inc. 28 Dec 2022 9 -$88,253 4 Possible Member of 10% Group, 10%+ Owner 30 Dec 2022, 18:16
ONCR Oncorus, Inc. 22 Dec 2022 6 -$19,896 4 Possible Member of 10% Group, 10%+ Owner 27 Dec 2022, 17:33
ONCR Oncorus, Inc. 19 Dec 2022 9 -$37,627 4 *Possible Member of 10% Group, 10%+ Owner 21 Dec 2022, 18:09
ONCR Oncorus, Inc. 13 Dec 2022 9 -$5,332 4 *Possible Member of 10% Group, 10%+ Owner 15 Dec 2022, 17:50
CMAX CareMax, Inc. 17 Nov 2022 1 $0 4 Director, Director by Deputization, 10%+ Owner 21 Nov 2022, 18:31
FLAC Frazier Lifesciences Acquisition Corp 08 Nov 2022 0 $0 3 Possible Member of 10% Group, 10%+ Owner 14 Nov 2022, 17:12
SPRY ARS Pharmaceuticals, Inc. 08 Nov 2022 0 $0 3 Director, Director by deputization, 10%+ Owner 10 Nov 2022, 18:48
NUVL Nuvalent, Inc. 03 Nov 2022 1 $21,775,000 4 Director, Director by deputization, 10%+ Owner 07 Nov 2022, 17:24
LRMR Larimar Therapeutics, Inc. 16 Sep 2022 4 $34,999,990 4 Director, * Director by Deputization, 10%+ Owner 20 Sep 2022, 20:31
AFIB Acutus Medical, Inc. 30 Jun 2022 2 $0 4 Director, Director by Deputization, 10%+ Owner 05 Jul 2022, 17:27
AFIB Acutus Medical, Inc. 16 Jun 2022 4 $0 4 Director, Director by deputization 20 Jun 2023, 20:10
NUVL Nuvalent, Inc. 16 Jun 2022 2 $0 4 Director, Director by Deputization, 10%+ Owner 21 Jun 2022, 16:14
MIRM Mirum Pharmaceuticals, Inc. 06 Jun 2022 6 -$962,255 4 * Possible Member of 10% Group, 10%+ Owner 08 Jun 2022, 19:25
LRMR Larimar Therapeutics, Inc. 10 May 2022 1 $0 4 Director, * Director by Deputization, 10%+ Owner 11 May 2022, 17:42
PEPG PepGen Inc. 10 May 2022 6 $4,999,992 4 Possible Member of 10% Group, 10%+ Owner 10 May 2022, 18:22
PEPG PepGen Inc. 05 May 2022 0 $0 3 *Possible Member of 10% Group, 10%+ Owner 05 May 2022, 20:00
TOIIW Oncology Institute, Inc. 12 Nov 2021 11 $100,000,000 4 Possible Members of 10% Group, 10%+ Owner 16 Nov 2021, 20:34
XLO Xilio Therapeutics, Inc. 26 Oct 2021 6 $12,400,000 4 Possible Member of 10% Group, 10%+ Owner 28 Oct 2021, 19:15
XLO Xilio Therapeutics, Inc. 21 Oct 2021 0 $0 3 *Possible Member of 10% Group, 10%+ Owner 21 Oct 2021, 21:36
NUVL Nuvalent, Inc. 02 Aug 2021 14 $10,200,000 4 Director, Director by Deputization, 10%+ Owner 04 Aug 2021, 18:05
NUVL Nuvalent, Inc. 28 Jul 2021 2 $0 4 Director, Director by Deputization, 10%+ Owner 30 Jul 2021, 17:27
NUVL Nuvalent, Inc. 28 Jul 2021 0 $0 3 Director, Director by Deputization, 10%+ Owner 28 Jul 2021, 18:58
AFIB Acutus Medical, Inc. 19 Jul 2021 2 $14,999,992 4 Director, Director by Deputization, 10%+ Owner 21 Jul 2021, 17:14
MIRM Mirum Pharmaceuticals, Inc. 09 Jul 2021 1 -$1,570,328 4 * Possible Member of 10% Group, 10%+ Owner 13 Jul 2021, 12:06
MIRM Mirum Pharmaceuticals, Inc. 02 Jul 2021 3 -$1,086,221 4 * Possible Member of 10% Group, 10%+ Owner 07 Jul 2021, 18:48
LRMR Larimar Therapeutics, Inc. 30 Jun 2021 3 $5,999,962 4 Director, * Director by Deputization, 10%+ Owner 02 Jul 2021, 17:07
AFIB Acutus Medical, Inc. 17 Jun 2021 2 $0 4 Director, Director by Deputization, 10%+ Owner 02 Sep 2021, 20:17
CMAX Deerfield Healthcare Technology Acquisitions Corp. 08 Jun 2021 8 $100,000,000 4 Director, Director by Deputization, 10%+ Owner 10 Jun 2021, 17:48
OMIC Singular Genomics Systems, Inc. 01 Jun 2021 8 $33,315,609 4 *Possible Member of 10% Group, 10%+ Owner 03 Jun 2021, 17:04
OMIC Singular Genomics Systems, Inc. 26 May 2021 0 $0 3 *Possible Member of 10% Group, 10%+ Owner 26 May 2021, 21:24
LRMR Larimar Therapeutics, Inc. 12 May 2021 1 $0 4 Director, * Director by Deputization, 10%+ Owner 17 May 2021, 17:17